Clinical Trials Logo

Clinical Trial Summary

The aim of this project is to conduct a multi-site effectiveness study to determine whether the addition of a monthly injection of depot naltrexone to treatment as usual (TAU) will significantly improve outcome in parolees and probationers with a history of opioid addiction compared to TAU alone. Participants will be randomized to either treatment as usual in community programs or monthly injections of depot naltrexone for six months with treatment as usual in community programs. The effectiveness of depot naltrexone has never been studied in opioid dependent parolees. all parolee subjects will be evaluated at baseline, while in treatment, and at 6, 12 and 18 month post entry time points. The primary study outcomes are retention in treatment, drug use, re-arrests, psychosocial and medical/psychiatric functioning, and economic costs and benefit costs of naltrexone.


Clinical Trial Description

This site serves as the coordinating center for five sites conducting the trial under the same IND and same protocol. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT00781898
Study type Interventional
Source University of Pennsylvania
Contact
Status Completed
Phase Phase 2/Phase 3
Start date June 2008
Completion date August 2015

See also
  Status Clinical Trial Phase
Completed NCT02539823 - Acute and Short-term Effects of CBD on Cue-induced Craving in Drug-abstinent Heroin-dependent Humans Phase 2
Recruiting NCT01934751 - Effectiveness of a Hospital Addiction Service in Treating Opioid and Alcohol Addiction N/A
Completed NCT00913770 - Models of Screening, Brief Intervention With a Facilitated Referral to Treatment (SBIRT) for Opioid Patients in the Emergency Department N/A
Completed NCT00929253 - Efficacy of Computer Delivered Community Reinforcement Approach (CRA) (Bup II) N/A
Terminated NCT02741076 - Discontinuation vs Continuation of Long-term Opioid Therapy in Suboptimal and Optimal Responders With Chronic Pain Phase 4
Completed NCT03015597 - Pilot Study of Contingency Management for Smoking Cessation N/A
Completed NCT02571400 - Prevalence and Predictors of Prolonged Post-surgical Opioid Use: a Prospective Observational Cohort Study N/A
Terminated NCT00552578 - Buprenorphine as a Treatment in Opiate Dependent Pain Patients Phase 4
Completed NCT00253890 - Insomnia and Drug Relapse Risk Phase 3
Completed NCT02667158 - A Survey to Eval the Relation Between Doctor/Pharmacy Shopping and Outcomes Suggestive of Misuse, Abuse and/or Diversion
Completed NCT02667210 - Study to Eval Relation Btw Doctor/Pharmacy Shopping & Outcomes of Misuse, Diversion, Abuse, Addiction by Med Rec Review
Active, not recruiting NCT01021566 - Opiate Detoxification Using the Combined Hemoperfusion-hemodialysis Phase 3
Withdrawn NCT01015066 - Comparison of Buprenorphine/Naloxone With Naltrexone in Opioid Dependent Adolescents Phase 4
Completed NCT02660619 - Validation of PRISM-5-Op, Measure Of Addiction To Prescription Opioid Medication
Active, not recruiting NCT02751762 - A Prospective Investigation of the Risks of Opioid Misuse, Abuse, and Addiction Among Patients Treated With Opioids for the Treatment of Chronic Pain
Completed NCT02657148 - Immediate Postpartum Nexplanon Placement in Opioid Dependent Women
Completed NCT02362256 - The Comparison of Stress Response to Rapid Opioid Detoxification Applying Different Methods of Opioid Antagonism N/A
Completed NCT01605539 - Acute and Short-term Effects of Cannabidiol Admin on Cue-induced Craving in Drug-abstinent Heroin Dependent Humans Phase 2
Completed NCT00204243 - Naltrexone Implants vs. MMT Among Inmates in the Norwegian Correctional Services Phase 2
Completed NCT02667262 - An Observational Study to Develop Algorithms for Identifying Opioid Abuse and Addiction Based on Admin Claims Data